REFERENCES
- Cooper MJ, Steinberg SM, Chatten J, et al. Plasticity of neuroblastoma tumor cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival. J Clin Invest 1992;90:2402–2408.
- Cooper MJ, Hutchins GM, Cohen PS, et al. Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ 1990;1:149–159.
- Kramer K, Gerald WL, Kushner BH, et al. Disialoganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. Clin Cancer Res 1998;4:2135–2139.
- Kramer K, Gerald WL, Kushner BH, et al. Disialoganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. Med Pediatr Oncol 2001;36:194–196.
- Miyauchi J, Kiyotani C, Shioda Y, et al. Unusual chromaffin cell differentiation of a neuroblastoma after chemotherapy and radiotherapy: report of an autopsy case with immunohistochemical evaluations. Am J Surg Pathol 2004;28:548–553.
- Hu J, Wu J, Cai L, et al. Retroperitoneal composite pheochromocytoma-ganglioneuroma: a case report and review of literature. Diagn Pathol 2013;8: 63–67.
- Lloyd RV, Blaivas M, Wilson BS. Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullary tissues. Arch Pathol Lab Med 1985;109:633–635.